NFE2L1 and pancreatic insulinoma: NFE2L1 knockdown was also shown to promote insulinoma cell proliferation and invasion in vitro and chemoresistance in a murine allograft transplantation model, highlighting NFE2L1 as a potential tumor suppressor.51